Skip to main content
logo
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.260
+0.090 (4.15%)
At close: Sep 2, 2026, 4:00 PM EDT
2.210
-0.050 (-2.21%)
After-hours: Sep 2, 2026, 6:37 PM EDT

TherapeuticsMD Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.273.021.761.369.962.57
Revenue Growth
27.78%71.61%35.25%-98.14%2619.12%-96.03%
Gross Profit
3.273.021.761.368.571.17
Operating Income
-1.75-2.37-3.49-8.5210.66-71.58
Net Income
-0.22-0.57-2.18-10.28112-172.42
Earnings Per Share
-0.02-0.05-0.19-0.9911.95-21.66
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.197.485.064.3338.0764.91
Total Debt
5.566.17.188.018.76197.69
Net Cash (Debt)
3.631.39-2.12-3.6829.31-132.79
Net Cash Growth
------
Net Cash Per Share
0.310.12-0.18-0.353.13-16.68

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3.122.420.73-48.14-4.08-142.69
Capital Expenditures
------0.03
Free Cash Flow
3.122.420.73-48.14-4.08-142.73
Free Cash Flow Growth
272.76%231.15%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%98.00%45.51%
Operating Margin
-53.55%-78.33%-198.30%-654.61%15.24%-2781.85%
Pretax Margin
-8.04%-21.61%-133.05%-594.62%1.54%-3082.20%
Profit Margin
-6.64%-18.83%-123.85%-789.40%160.08%-6700.93%
FCF Margin
95.41%80.21%41.57%-3697.46%-5.83%-5547.10%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----0.47-
Forward PE
-25.0925.0925.09--
P/FCF Ratio
8.277.7813.55---
PS Ratio
7.896.245.6319.790.7658.71